We provide a protocol for precision nuclear run-on sequencing (pro-seq) and its variant, pro-cap, which map the location of active rna polymerases (pro-seq) or transcription start sites (tsss) (pro-cap) genome-wide at high resolution. the density of rna polymerases at a particular genomic locus directly reflects the level of nascent transcription at that region. nuclei are isolated from cells and, under nuclear run-on conditions, transcriptionally engaged rna polymerases incorporate one or, at most, a few biotin-labeled nucleotide triphosphates (biotin-ntps) into the 3′ end of nascent rna. the biotin-labeled nascent rna is used to prepare sequencing libraries, which are sequenced from the 3′ end to provide high-resolution positional information for the rna polymerases. pro-seq provides much higher sensitivity than chIp-seq, and it generates a much larger fraction of usable sequence reads than chIp-seq or net-seq (native elongating transcript sequencing). similarly to net-seq, pro-seq maps the rna polymerase at up to base-pair resolution with strand specificity, but unlike net-seq it does not require immunoprecipitation. With the protocol provided here, pro-seq (or pro-cap) libraries for high-throughput sequencing can be generated in 4-5 working days. the method has been applied to human, mouse, Drosophila melanogaster and Caenorhabditis elegans cells and, with slight modifications, to yeast.
IntroDuctIon
The ability to measure the density of RNA polymerase across the genome provides a comprehensive and quantitative snapshot of transcription 1 . Collecting a series of these snapshots in response to regulatory switches reveals the identity of genes that respond immediately or secondarily to specific signals, and it provides critical insights into the mechanisms of their regulation 2 . Quantification of RNA polymerase density along the genes is also critical for deciphering the regulatory steps involved in transcription.
In addition to protein-coding genes, many other regions in the genome (such as upstream divergent regions, regions downstream of mRNA poly A sites and enhancers) are transcribed to various extents. Enhancers produce short unstable RNAs (eRNAs) that do not encode proteins 3 but delineate major hubs of transcription regulation 4 . Differential regulation of enhancer-mediated transcription is implicated in various diseases 5 , and understanding this regulation is important for deciphering the transcriptional changes in response to developmental, nutritional and environmental cues. However, sequencing of total RNA by RNA-seq is inefficient in detecting these unstable RNAs.
A number of methods have been described that enrich and sequence nascent RNAs associated with RNA polymerase. These methods either are based on immunoprecipitation of RNA polymerase [6] [7] [8] or are dependent on the purification of insoluble chromatin 9 . Therefore, these methods are highly dependent on antibody specificity or the purity of the chromatin fraction, respectively. We have developed nuclear run-on-based methods to map active RNA polymerases and their start sites genome-wide at up to base-pair resolution 10, 11 . In these methods, the endogenous activity of RNA polymerase is used to selectively label nascent RNAs. The ability to affinity-purify nuclear run-on RNA multiple times during the course of library preparation provides an approximate million-fold enrichment of the nascent RNA over other forms of RNA and thereby effectively eliminates background 10 . Furthermore, because the RNA is sequenced, the direction of transcription can be unambiguously identified.
Development of PRO-seq
PRO-seq is based on global run-on sequencing (GRO-seq), a genome-wide adaptation of nuclear run-on assays that have been used classically to measure transcription of target genes. In GRO-seq, bromouridine-labeled nascent RNAs are affinitypurified and analyzed by high-throughput sequencing to map RNA polymerase positions. Extremely high sensitivity and specificity is achieved through multiple distinct affinity-purification steps 10, 12 . GRO-seq uses bromouridine as the substrate for the nuclear run-on reaction, enabling RNA polymerase to add multiple nucleotides to the nascent RNA. Therefore, the resolution of GRO-seq is on the order of tens of bases.
However, to understand the molecular mechanisms of transcriptional elongation and promoter-proximal pausing, RNA polymerase mapping at base-pair resolution is required. Such resolution enables mechanistic modeling of how DNA sequences, nucleosomes or other DNA-binding factors affect RNA polymerase elongation and gene expression 2, 13 . To achieve base-pair resolution, we used a modified nuclear run-on that Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq) limits the number of labeled nucleotides added to the nascent RNA 10, 11, [14] [15] [16] . In PRO-seq, biotin-labeled NTPs are provided as the substrates for the nuclear run-on reaction. The incorporation of a biotin-NTP by an RNA polymerase inhibits further incorporation of biotin-NTPs into the nascent RNA. Sequencing from the 3′ end of the nascent transcript therefore identifies the last incorporated NTP and reveals the precise location of the active site of the RNA polymerase engaged with its nascent RNA.
Identification of the precise position of TSSs is also important for understanding how DNA elements, general transcription factors and transcription activators recruit RNA polymerase to genes and enhancers. RNA polymerase initiates transcription at a TSS and quickly transcribes a short region before pausing at a promoter-proximal site. However, because the nascent transcripts are sequenced from the 3′ end in PRO-seq, the positional information of where RNA polymerase began transcription is mostly lost. We therefore developed PRO-cap by modifying the sequencing strategy of PRO-seq to sequence the capped nascent RNA from the 5′ end, enabling TSSs to be identified at the RNA synthesis level 11 .
Overview of the procedure A general overview of the PRO-seq and PRO-cap experimental procedures is shown in Figure 1 . Nuclei from cells are rapidly isolated, and native nucleotides are washed away to halt transcription. However, RNA polymerases remain engaged on the DNA and retain their enzymatic activity. Incubation of isolated nuclei with biotin-labeled NTPs allows the RNA polymerases to actively elongate and label the nascent RNA. For PRO-seq only, the labeled nascent RNA is hydrolyzed with NaOH to generate RNA fragments suitable for sequencing (~100 bp in length). The RNA containing a biotin nucleotide is then enriched by affinity purification using streptavidin-coated magnetic beads. The biotin-streptavidin interaction is very stable (K d ~ 10 −14 mol/l), which allows stringent washing of the magnetic beads to minimize contamination with unlabeled RNA. A 3′ sequencing adaptor is then ligated to the hydroxyl (OH) group at the 3′ end of nascent RNA, followed by another affinity purification to further enrich the nascent RNA and remove unligated adaptor sequences. Preparation for 5′ sequencing adaptor ligation differs for PRO-seq and PRO-cap. For PRO-seq, the 5′ cap is removed from unhydrolyzed short nascent RNA using either tobacco acid pyrophosphatase (TAP) or RNA 5′ pyrophosphohydrolase (RppH). The 5′ OH generated by base hydrolysis is then converted to 5′ phosphate by treatment with T4 polynucleotide kinase (PNK). For PRO-cap, uncapped RNA with a 5′-monophosphate is degraded using 5′-phosphate-dependent exonuclease. 5′-Triphosphates and monophosphates are removed from any remaining contaminating uncapped RNA with alkaline phosphatase. Only then is the 5′ cap of nascent RNA removed with TAP or RppH treatment. After these chemical modifications, a 5′ sequencing adaptor is ligated to the nascent RNA, and a third round of affinity purification is performed to enrich for nascent RNA with sequencing adaptors on both ends. Nascent RNA is then reverse-transcribed and test-PCR-amplified to determine an appropriate number of PCR cycles for final amplification; this latter step is critical to avoid over-amplification. During the final amplification, barcodes can be added so that multiple libraries can be pooled for sequencing. Finally, the PCR-amplified libraries are sizeselected for a range of 140-350 bp and sent for high-throughput sequencing. Sequencing depths of 25- Step 2
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Steps 147-150 RPI-n indexed primer is sufficient. The sequencing data are generated as a textbased list of short nucleotide sequences, and sequencing quality parameters are provided in a 'fastq' format 17 . The sequences may contain varying lengths of adaptor sequences, which are removed before aligning the adaptor-trimmed sequences to the appropriate genome. Finally, the aligned sequences are used to generate coverage files that can be used to visualize and analyze the data.
Advantages and limitations of PRO-seq
The key advantages of PRO-seq are as follows:
It provides base-pair resolution and strand-specific information of global RNA polymerase occupancy. Background RNA contamination is hugely reduced because of almost a million-fold purification of biotinylated nascent RNAs. It is highly sensitive in detecting rare and common nascent RNAs with a large dynamic range (>10 5 ). It can identify short unstable nascent RNAs transcribed from enhancer regions.
PRO-seq also has a number of limitations that should be considered when deciding which genome-wide RNA polymerase mapping strategy to use.
In principle, PRO-seq results are ensemble profiles of potentially heterogeneous populations of cells-and this is generally true for all multicell, high-throughput sequencing analyses. Unlike mature RNA molecules that are present in multiple copies per cell, RNA polymerase at a specific genomic position can yield at most only two copies of nascent RNA. Therefore, although it may be possible to adapt PRO-seq to measure nascent transcript levels for abundantly expressed genes in single cells, genomewide mapping of RNA polymerase in single cells using PRO-seq would remain a challenge. PRO-seq detects only the active RNA polymerase, and thus RNA polymerases in the preinitiation complex will not be detected. There is also a possibility that other forms of stalled RNA polymerases, such as back-tracked polymerases, may not be detected, although nuclear run-on conditions may allow some of these polymerases to re-align the active site through thermal motion. Generally, the signals seen by ChIP-seq of RNA polymerase II (Pol II) and our genome-wide run-on methods quantitatively agree 18 , so the bulk of Pol II is detectable by GRO-and PRO-seq methods. Compared with GRO-seq, which adds a longer extension to the 3′ end of nascent RNA 10 , PRO-seq adds only one or a few nucleotides in order to provide higher-resolution mapping. However, there is a possibility that RNA polymerases positioned very close to the TSS may not be detected because the nascent RNA may not be long enough to be uniquely mapped to the genome. In this case, GRO-seq may provide more accurate quantification of promoter-proximal RNA polymerases. Similarly, RNA polymerases positioned in a repetitive sequence region of the genome are difficult to unambiguously map to a particular repeat. PRO-seq does not distinguish nascent transcription derived from different RNA polymerases (Pol I versus Pol II versus Pol III) unless it is carried out in the presence of inhibitors of specific RNA polymerases. In addition, unlike NET-seq, nascent RNA associated with specific RNA polymerase modifications (e.g., phosphorylations of the C-terminal domain) cannot be selectively detected using PRO-seq 8 .
•
Applications of PRO-seq and PRO-cap
The most common use of PRO-seq is for the analysis of genomewide transcription levels with directional information and with higher resolution and sensitivity than an RNA polymerase ChIP-seq assay. PRO-seq provides an independent layer of gene expression analysis distinct from that of mRNA-seq, revealing the transcriptional stages of regulation before the influence of mRNA processing or stability control. The increased resolution and the directional information become useful in distinguishing upstream divergent (also called upstream antisense) transcription 10, 19 . PRO-cap 11 can capture TSSs at the nascent RNA synthesis level, in contrast to other TSS analyses that use mature RNA [20] [21] [22] . This becomes an advantage in detecting enhancer transcripts 3, 23, 24 , upstream antisense transcription 3, 10 or other types of unstable transcripts, and avoiding post-transcriptional background capping events 25 .
Alternatives to PRO-seq RNA polymerase can be mapped genome-wide by a variety of different strategies.
ChIP-seq. In this approach, RNA polymerase proteins are crosslinked to the DNA, and then Pol II is purified by immunoprecipitation. Pol-II-associated DNA is identified and quantified by high-throughput sequencing, thereby providing an estimate of the amount of Pol II at different sites on the genome. The resolution of ChIP is usually limited by the size of the fragmented DNA in the chromatin at the immunoprecipitation step. A variant of this method, called ChIP-exo, overcomes the resolution limitation by additionally treating the DNA fragments from the Pol II ChIP with a DNA exonuclease 26 . The exonuclease digests DNA from the 3′ end of both strands, stopping near the crosslinked polymerase complex. An additional limitation of ChIPseq is that Pol-II-unbound genomic regions that interact with a Pol-II-bound region through three-dimensional looping can be falsely identified with this method because of the use of cross-linking. Finally, ChIP-seq will map all forms of Pol II, including transcriptionally inactive Pol IIs and Pol IIs in antisense orientation; therefore, the direction of the transcription is not directly disclosed. Permanganate footprinting. This method can be used to identify the single-stranded DNA created by the transcription bubble formed on DNA by the RNA polymerase. The nontemplate strand of the DNA is exposed to single-strand-specific breakage at T residues through a series of chemical treatments. A method called permanganate-ChIP-seq couples permanganate footprinting to Pol II ChIP and thereby maps the cleaved ends of the DNA from the single-stranded region of transcription bubbles 27 . This directly maps the transcription active site with high resolution. Permanganate mapping depends on the presence of thymine residues in the nontemplated single-stranded DNA of the bubble that are not masked by protein binding. Although the protocol enriches for Pol II in a single chromatin immunoprecipitation, other regions that expose single-stranded thymine-such as in other DNA-RNA hybrids or intrastrand DNA hairpins-could contribute to background. NET-seq. A number of chromatin-bound nascent-RNAbased methods, including NET-seq and its variants, have been developed for mapping RNA polymerase 6, 8, 9, 28 . In the original
NET-seq protocol 6 , the RNA polymerase complex is immunoprecipitated and the co-purified native RNA is sequenced. The 3′ end of the nascent RNA provides base-pair-resolution mapping of RNA polymerase. This method is ideally suited to examining the occupancy of differently modified RNA polymerases. In practice, the efficiency of NET-seq relies on the degree of enrichment provided by the single immunoprecipitation step. Because the method detects the 3′ ends of all RNAs that are associated with Pol II, it also captures the 3′ ends of intermediates of co-transcriptional splicing and micro-RNA production that can complicate mapping of transcriptionally engaged Pol II (ref. 8) .
Experimental design
Cells. In our lab, we have successfully generated PRO-seq libraries for cells from plants (G.T.B., unpublished data), yeast (G.T.B., unpublished data), Drosophila 11 and mammals 3, 29 . In general, the higher the number of cells, the better the PRO-seq read coverage of the genome. However, a minimum of 5-10 million nuclei or permeabilized cells is required for a single PRO-seq library, regardless of cell type. In principle, the application of PRO-seq in yeast, including Schizosaccharomyces pombe and Saccharomyces cerevisiae, is very similar to that in other organisms; however, some alterations are required in yeast cell permeabilization 30 , run-on reaction and post-run-on RNA extraction procedures 31 ; required modifications for yeast are indicated in the appropriate steps of the PROCEDURE.
Sample preparation. Isolation of nuclei for nuclear run-on is a critical step in the procedure not only to preserve the enzymatic activity of the RNA polymerase but also to capture the precise position of the RNA polymerase on genes. Starting with 10-20 million cells per library is recommended, considering the efficiency of the nuclei isolation process (~50%). The whole process should take place in a cold room on ice as far as is possible. Isolated nuclei can be resuspended in the glycerol-containing storage buffer, and they can be quickly frozen in liquid nitrogen for long-term storage at −80 °C. We have used permeabilized cells in PRO-seq as an alternative to isolating nuclei, which makes handling easier and reduces loss of sample; cell permeabilization has a much higher efficiency (~90%) than nuclei isolation. Cell permeabilization conditions may differ between cell types and may need to be optimized; we provide a general method for permeabilization in the PROCEDURE, as well as a version optimized for yeast cells.
Spike-in for library normalization. Disproportionate loss of RNA and/or cDNA can occur during multiple stages of the PROseq library preparation, which spans 4-5 d and involves several handling steps. Even with the use of identical starting material, uneven loss of libraries could affect the genome-wide RNA polymerase density between libraries. To control for handling effects on library yield, a small fraction (1-5%) of cells with a distinct genome can be added during library preparation; adding an identical number of spike-in cells to different libraries enables normalization between different conditions. We have used S. pombe to normalize S. cerevisiae (and vice versa) and Drosophila cells to normalize mammalian cells (and vice versa). When the cell permeabilization approach is used, spike-in cells should be added and permeabilized together with the experimental cells. For the nuclei isolation approach, spike-in cells should be added to the experimental cells before nuclei isolation, and the cells should be dounced together.
Nuclear run-on. In PRO-seq, biotin-NTPs are used as the nuclear run-on substrates. The K m of each of the NTPs as substrates for RNA polymerase lie in the range of 1-20 µM (ref. 32) . Therefore, a final substrate concentration greater than a 1-20 µM range (~25 µM) is, in general, sufficient for each biotin-NTP substrate. Depending on the purpose of the experiment, biotin-NTP substrates can be supplied in different combinations: individual-biotin run-on, 4-biotin run-on, 2-biotin run-on or 1-biotin run-on.
Individual-biotin run-on. To obtain the most precise mapping of the RNA polymerase, four separate PRO-seq libraries should be made, each supplied with only one type of biotin-NTP in the nuclear run-on reaction. This ensures that the RNA polymerase adds only one, or at most a few (when the polymerase is positioned at multiple stretches of same nucleotide), biotinNTPs to the nascent RNA. In this case, four times more sample is required.
4-Biotin run-on.
We found that all four biotin-NTPs can be supplied in a single reaction and the Pol II incorporates only one or at most a few bases, giving an equivalent resolution to that of an individual-biotin run-on. The reason for this is unclear, but we speculate that steric hindrance in the active site of the RNA polymerase prevents incorporation of multiple biotinylated nucleotides.
2-Biotin run-on.
When the amount of sample or the cost is limited, unlabeled NTPs can be used in combination with biotin-NTPs. The use of biotinylated purine nucleotides (biotin-ATP, biotin-GTP) is more costly than that of the pyrimidine nucleotides (biotin-CTP, biotin-UTP). A combination of biotin-CTP, biotin-UTP, ATP and GTP can be supplied to the nuclear run-on reaction, providing reasonable resolution and cost. 1-Biotin run-on. If a longer run-on RNA is preferred, combinations of biotin-CTP with unlabeled CTP, UTP, ATP and GTP can be used effectively in a biotin-NTP form of GRO-seq. This approach can be useful for increasing sequencing coverage of RNA polymerases that reside near the TSSs. Although most transcriptionally engaged RNA polymerases near the 5′ ends reside between 30 and 60 nucleotides from the TSS 11 , RNA polymerases closer to the TSS may fail to map uniquely. In addition, the longer run-on extensions of nascent RNAs may be desired for distinguishing allele-specific nascent transcription.
PCR amplification of the PRO-seq library. When the number of cells and/or nuclei is limited for PRO-seq library preparation, a higher number of PCR amplification cycles will be required to generate a sufficient library for reliable quantification and accurate loading into the sequencer. However, a higher number of PCR cycles can result in amplification bias of some sequences. To avoid PCR-induced biases, molecular barcodes 33 can be introduced as part of the 3′ RNA adaptor, which is ligated to the nascent RNAs. Duplicate reads generated by PCR overamplification can be identified by identical barcodes and computationally filtered at the stage of mapping the sequenced reads to the genome. • 1 N NaOH Dissolve 2 g of NaOH in 50 ml of DEPC-H 2 O, and filter-sterilize the solution with a 0.22-µm filter.  crItIcal 1 N NaOH can be prepared in advance and stored in 50-µl aliquots at −80 °C for up to a year. Use a freshly thawed aliquot each time. ! cautIon NaOH is corrosive, and contact with skin or eyes or inhalation should be avoided. 10% (vol/vol) Triton X-100 Dissolve 5 ml of Triton X-100 in 45 ml of DEPC-H 2 O and filter-sterilize the solution with a 0.22-µm filter.  crItIcal 10% (vol/vol) Triton X-100 can be prepared in advance and stored at room temperature for up to a year. 10% NP40 Dissolve 5 ml of NP40 in 45 ml of DEPC-H 2 O and filter-sterilize the solution with a 0.22-µm filter.  crItIcal 10% NP40 can be prepared in advance and stored at room temperature for up to a year. 2% Sarkosyl Dissolve 1 g of Sarkosyl in 50 ml of DEPC-H 2 O and filter-sterilize the solution with a 0.22-µm filter. ! cautIon Sarkosyl is an irritant, and contact with skin or eyes, or inhalation should be avoided.  crItIcal 2% Sarkosyl can be prepared in advance and stored at room temperature for up to a year. sample preparation • tIMInG 1 h  crItIcal Samples should be prepared in a cold room (4 °C) to avoid unsolicited run-on.
2| Prepare samples by isolating nuclei (option A) or by cell permeabilization (use option C for yeast cells and option B for other cell types).
All centrifugation steps for sample preparation are performed in a cold centrifuge (4 °C) at 1,000g (unless otherwise stated) for 5 min. 6| Using a cut-off P200 pipette tip, add 100 µl of nuclei or permeabilized cells (in storage buffer from
Step 2) to 100 µl of preheated 2× reaction mix, gently but thoroughly pipette the mixture 15 times and place it in a heat block at the appropriate temperature.  crItIcal step Sarkosyl in the 2× reaction mix causes the run-on mixture to become very viscous (except for yeast). When adding the nuclei or permeabilized cells to the reaction mix and when mixing by pipetting up and down, use a wide-bore pipette tip or cut the last centimeter off a normal one with ethanol-wiped clean scissors or a razor blade. 
10|
Incubate the sample at room temperature for 10 min.
11|
Centrifuge the sample at 14,000g for 20 min at 4 °C. The RNA precipitate forms a gel-like pellet on the side and bottom of the tube.
12|
Remove the supernatant completely.
13| Add 750 µl of 75% (vol/vol) ethanol.  pause poInt The RNA pellet in 75% (vol/vol) ethanol can be stored for up to a week at −80 °C.
14|
Mix the sample by vortexing, and centrifuge it at 14,000g for 5 min at 4 °C.
15|
Remove all of the supernatant.
16| Air-dry the RNA pellet for 5-10 min.  crItIcal step It is important not to let the RNA pellet dry completely, as this will greatly decrease its solubility. 
17|

21|
Perform buffer exchange once by running the 50-µl base-hydrolyzed RNA sample through a P-30 column according to the manufacturer's instructions.
22| Add 1 µl of RNase inhibitor.
biotin rna enrichment • tIMInG 3 h 23| Mix ~50 µl of the RNA sample from Step 22 for PRO-seq or from Step 17 for PRO-cap with 50 µl of prewashed streptavidin beads.
24|
Incubate the bead mixture at room temperature on a rotator set at 8 r.p.m. for 20 min.
25|
Place the mixture on a magnet for 1 min and remove the liquid.
26|
Resuspend the beads in 500 µl of ice-cold high-salt wash buffer for a 1-min wash using a rotator.
27|
Place the mixture on a magnet for 1 min, and remove the buffer.
28| Repeat Steps 26 and 27.
29| Wash the beads two times with 500 µl of binding buffer for a minute and use the magnet to facilitate removal of buffer.
30|
Wash the beads once with 500 µl of low-salt wash buffer.
31|
Resuspend the beads in 300 µl of Trizol and vortex them thoroughly.
32|
Incubate the beads for 3 min at room temperature.
33| Add 60 µl of chloroform.  crItIcal step Inaccurate pipetting of chloroform leads to incomplete phase separation of the Trizol when transferring a small volume.
34|
Vortex the beads thoroughly (for more than 20 s) and incubate the tubes for 3 min at room temperature.
35|
Centrifuge the beads at 14,000g for 5 min at 4 °C.
36|
Transfer ~180 µl of the aqueous layer to a new tube.
37|
Remove and discard the organic phase, leaving the beads and the unpipetted aqueous phase.
38|
Extract RNA from the beads once more by repeating Steps 31-35.
39| Collect ~180 µl of the aqueous layer and combine it with the sample from Step 36.
40| Add 360 µl of chloroform to the pooled aqueous layer and vortex the mixture.
41|
Centrifuge the mixture at 14,000g for 5 min at 4 °C.
42|
Transfer ~350 µl of the aqueous layer to a clean tube.
43|
To the collected aqueous layer, add 1 µl of GlycoBlue and 900 µl of 100% (vol/vol) ethanol and vortex. 58| Heat-denature the mixture briefly at 65 °C in a heat block for 20 s, and then place it on ice.
59|
If you are performing PRO-cap, degrade the uncapped RNA containing 5′-monophosphate, and remove the 5′-triphosphate and monophosphate from uncapped RNA, as described in box 1 (supplementary tables 3 and 4), before proceeding to
Step 60. For PRO-seq, continue directly to Step 60.
60|
Prepare 5′ cap repair enzyme mix, depending on the availability of TAP or RppH. When using TAP, prepare the enzyme mix in the first 
62|
Incubate the mixture at 37 °C for 1 h.
63| For PRO-seq, proceed to
Step 64 for hydroxyl repair. For PRO-cap, add 90 µl of DEPC H 2 O to the 10 µl of RNA from
Step 62 and proceed directly to Step 67.
Hydroxyl repair (pro-seq only)
• tIMInG 2 h 64| Prepare PNK mix as shown below. When processing multiple samples, scale up accordingly (supplementary table 6). 
66|
67|
Add 300 µl of Trizol and vortex the mixture for 5 s.
68|
Add 60 µl of chloroform, vortex for 15 s and incubate the mixture for 2 min at room temperature.
69|
70|
Transfer ~280 µl of the aqueous layer to a clean microcentrifuge tube. 71| Add 280 µl of chloroform to the aqueous layer from Step 70 and vortex for 5 s.
72|
Centrifuge the mixture at 14,000g for 5 min at 4 °C, and transfer ~280 µl of the aqueous layer to a clean microcentrifuge tube. 76| Re-dissolve the RNA pellet from
73|
Step 74 in 4 µl of the 5′ RNA adaptor dilution.
77|
Heat-denature the mixture at 65 °C in a heat block for 20 s, and then place it on ice.
78| Make the RNA ligation mix, as described in Step 52. When processing multiple samples, scale up accordingly (supplementary table 2 ).
79| Add 6 µl of the RNA ligation mix to the 4 µl of RNA (10 µl final).  crItIcal step GlycoBlue may form a precipitate in the presence of high PEG concentrations, but it is not reported to affect the ligation efficiency.
80|
Incubate the mixture at 20 °C for 4 h, and then store it at 4 °C until ready to proceed to the next step.  pause poInt The ligation reaction can be left at 4 °C overnight.  crItIcal step As only 6 µl out of the total 8 µl of dilution 1 is used for PCR, this is equivalent to using 1.5 µl (6/8 × 2) of the original 26-µl RT sample, which is 16-fold less than the remaining 24-µl RT sample. Thus, to account for the 16-fold-higher amount of starting material in the full-scale amplification, the number of PCR cycles needs to be reduced by four compared with the test PCR of dilution 1-i.e., 17 cycles instead of 21. Each remaining dilution in the fourfold dilution series will need to be corrected by a further two cycles compared with the previous dilution-i.e., 15, 13 and 11 cycles for dilutions 2-4, respectively. 114| Load the samples. Also load 2 µl of 10-bp DNA ladder and 8 µl of 100-bp DNA ladder.
94|
115|
Run the gel at 15 mA for 30 min until the DNA has entered the gel, and then run it at 30 mA for 1.5 h. Stop electrophoresis 10 min after the Orange G dye has run off the gel.
116|
During the electrophoresis, puncture the bottom of a sterile, nuclease-free, 0.5-ml centrifuge tube using a 21-gauge needle (heated in a Bunsen flame) to create a hole or several holes in the bottom of the tube. Place the 0.5-ml microtube into a sterile, round-bottom, nuclease-free, 2-ml microtube.
117|
After the electrophoresis, pry apart the gel cassette and stain the gel with SYBR Gold (10 µl of SYBR Gold per 100 ml of 1× TBE buffer) in a clean container for 5-10 min.
118|
Visualize the gel on a Dark Reader transilluminator.
119| Using a clean scalpel or razor, cut the gel from 140 bp (20 bp just above the 120-bp adaptor dimer) up to 350 bp ( Fig. 2c-e) .
120| Split the gel fragment vertically, and place the pieces into the 0.5-ml microtube.
121|
Centrifuge the stacked tubes at 10,000g for 2 min at room temperature to shred the gel through the holes into the 2-ml tube (there is no liquid at this point).
122| If some gel remains in the top tube, add 100 µl of gel elution buffer and spin it at 10,000g again for another 2 min.
123| Add 600 µl of gel elution buffer and incubate for 2 h in a rotating incubator at 37 °C.  pause poInt The elution can continue overnight.
124|
Spin down the gel pieces for 1 min at max speed in a benchtop centrifuge.
125|
Transfer all liquid possible to a new tube.
126| Add 400 µl of gel elution buffer to the remaining gel pieces.
127|
Incubate the mixture for 1 h in a rotating incubator at 37 °C.
128| After 1 h incubation, spin at the maximum speed in a benchtop centrifuge for 1 min; take the supernatant and pool it with the first elution from Step 125.
129|
Rinse the gel pieces with 250 µl of H 2 O; spin and add the rinsed liquid to the pool.
130|
Transfer the pooled eluate, which may contain small pieces of gel debris, to the top of a Spin-X Filter.
131|
Centrifuge the filter for 1-2 min at 6,000-7,000g at room temperature. Collect the filtrate. If the volume exceeds the filter capacity, use multiple filters or split into batches and repeat filtering a couple of times, pooling the filtrates.
132| Lyophilize (on medium setting) the sample using a SpeedVac dryer and reduce the volume to ~400 µl (takes 45 min-2 h). If the volume decreases below 400 µl, bring the volume up to 400 µl by adding DEPC-H 2 O.
133|
Add an equal volume of buffered phenol:chloroform, and vortex the mixture thoroughly.
134|
135|
Collect the aqueous layer in a clean tube. 136| Add an equal volume of chloroform to the aqueous layer and vortex the mixture thoroughly.
137|
138|
Collect the aqueous layer in a clean tube.
139| Add 1 µl of GlycoBlue to the aqueous layer.
140| Add 2.5× volume of room-temperature 100% (vol/vol) ethanol.
141| Vortex thoroughly and incubate the mixture at room temperature for 10 min.
142|
Centrifuge the mixture at 14,000g for 20 min at 4 °C.
143|
Remove the liquid, and wash the DNA pellet once in 75% (vol/vol) ethanol by repeating Steps 45-48.
144|
Re-dissolve the pellet in 12 µl of H 2 O.
145| Use 2 µl of the library DNA for quantification using Qubit or Bioanalyzer. The expected concentration of the library is between 1 and 20 ng/µl.
146|
If required, dilute the samples to 5 ng/µl. Send ~10 ng to the sequencing facility for sequencing. If the libraries are barcoded, pool the barcoded libraries that are to be sequenced simultaneously.
High-throughput sequencing • tIMInG 24 h 147| Sequence pooled PRO-seq or PRO-cap libraries using an Illumina TRU-seq-compatible sequencing platform. A sequencing depth of ~20 million and ~50 million reads provides good coverage for insect cells and mammalian cells, respectively.
Data analysis • tIMInG variable
 crItIcal In PRO-seq, the 3′ end of the nascent RNA corresponds to the genomic position of the RNA polymerase active site. The modified RNA adaptors were designed to enable sequencing of the reverse complement of nascent RNAs. Therefore, the 3′ end of the reverse complement of the sequencing reads reflects the RNA polymerase active site position. In PRO-cap, conventional RNA adaptors are used, and the 5′ ends of each sequence read reflect the TSSs in the same direction. Below, we outline the three major stages of a simple processing pipeline. 148| Pre-process the raw sequence data. Filter out low-quality reads and trim potential adaptor sequences (TGGAATTCTCGGGTGCCAAGG) from the sequence reads. Tools such as 'cutadapt' are publicly available for this purpose.
Depending on the quality of the library, sequences containing only the adaptor sequences (adaptor dimers) may take up to 5% of total reads.
149|
Map or align the sequence reads to the genomic sequence. As most of the nascent RNA reads are captured before RNA processing and splicing, they do not contain large gaps in alignment. Therefore, many alignment programs based on the Burrows-Wheeler transformation algorithm-such as 'bwa' or 'bowtie'-work well. Reads with multiple alignments are usually discarded, unless they are used for studying specific target regions that are repeated more than once. Sometimes reads aligning to the ribosomal DNA sequence can be prefiltered, as they can account for 30-40% of all the transcriptional activity. On average, ~55-70% of the raw sequence reads are aligned uniquely to the genome. The alignment results are commonly stored in 'sam' or 'bam' formats.
150|
Generate the coverage of the aligned sequence reads. A common way to do this using publicly available tools is as follows: first, sort the 'bam' file using 'samtools sort'; then process the sorted 'bam' file using 'bedtools genomecov' with '-ibam' (use bam file input), '-strand' (strand-specific coverage) and '-5′ (5′ position coverage)' options. For the PRO-seq data, swap the plus and minus strand data for the correct orientation. These data can be visualized in genome browsers (Fig. 3) and used in further downstream analyses. 
antIcIpateD results
The final product of the PRO-seq or PRO-cap method is genome-wide maps of RNA polymerase active sites or TSSs, respectively (Fig. 3) . In general, the PRO-seq profile of a gene exhibits several features, such as higher read density at the promoterproximal pause site as compared with the gene body representing paused Pol IIs; uniform read density across exons and introns; reads beyond the polyadenylation site; and divergent PRO-seq reads at the promoter of mammalian genes, indicating divergent transcription. The enhancer regions, which are present in intergenic and intragenic regions, are also characterized by divergent PRO-seq reads. In PRO-cap, read density is very high at TSSs and very low, almost at background levels, in gene bodies.
An indication of whether library preparation has been successful can be obtained at the test amplification stage (Steps 93-101) through estimates of yield and quality (Fig. 2) . Spiky PRO-seq read coverage along the gene body indicates lower library complexity, which may arise from the use of too few nuclei or permeabilized cells or from the use of too many PCR amplification cycles. Libraries that require fewer amplification cycles (<13 cycles) provide high-quality results, and those requiring between 14 and 18 cycles provide meaningful results, but have some potential for amplification biases. These amplification biases manifest as low library complexity in general and high repetition of certain sequence reads.
